TY - JOUR
T1 - Diffusion-weighted hyperpolarized 129Xe MRI in healthy volunteers and subjects with chronic obstructive pulmonary disease
AU - Kaushik, S. Sivaram
AU - Cleveland, Zackary I.
AU - Cofer, Gary P.
AU - Metz, Gregory
AU - Beaver, Denise
AU - Nouls, John
AU - Kraft, Monica
AU - Auffermann, William
AU - Wolber, Jan
AU - McAdams, H. Page
AU - Driehuys, Bastiaan
PY - 2011/4
Y1 - 2011/4
N2 - Given its greater availability and lower cost, 129Xe apparent diffusion coefficient (ADC) MRI offers an alternative to 3He ADC MRI. To demonstrate the feasibility of hyperpolarized 129Xe ADC MRI, we present results from healthy volunteers (HV), chronic obstructive pulmonary disease (COPD) subjects, and age-matched healthy controls (AMC). The mean parenchymal ADC was 0.036 ± 0.003 cm2 sec-1 for HV, 0.043 ± 0.006 cm2 sec-1 for AMC, and 0.056 ± 0.008 cm2 sec-1 for COPD subjects with emphysema. In healthy individuals, but not the COPD group, ADC decreased significantly in the anterior-posterior direction by ∼22% (P = 0.006, AMC; 0.0059, HV), likely because of gravity-induced tissue compression. The COPD group exhibited a significantly larger superior-inferior ADC reduction (∼28%) than the healthy groups (∼24%) (P = 0.00018, HV; P = 3.45 × 10-5, AMC), consistent with smoking-related tissue destruction in the superior lung. Superior-inferior gradients in healthy subjects may result from regional differences in xenon concentration. ADC was significantly correlated with pulmonary function tests (forced expiratory volume in 1 sec, r = -0.77, P = 0.0002; forced expiratory volume in 1 sec/forced vital capacity, r = -0.77, P = 0.0002; diffusing capacity of carbon monoxide in the lung/alveolar volume (VA), r = -0.77, P = 0.0002). In healthy groups, ADC increased with age by 0.0002 cm2 sec-1 year-1 (r = 0.56, P = 0.02). This study shows that 129Xe ADC MRI is clinically feasible, sufficiently sensitive to distinguish HV from subjects with emphysema, and detects age- and posture-dependent changes.
AB - Given its greater availability and lower cost, 129Xe apparent diffusion coefficient (ADC) MRI offers an alternative to 3He ADC MRI. To demonstrate the feasibility of hyperpolarized 129Xe ADC MRI, we present results from healthy volunteers (HV), chronic obstructive pulmonary disease (COPD) subjects, and age-matched healthy controls (AMC). The mean parenchymal ADC was 0.036 ± 0.003 cm2 sec-1 for HV, 0.043 ± 0.006 cm2 sec-1 for AMC, and 0.056 ± 0.008 cm2 sec-1 for COPD subjects with emphysema. In healthy individuals, but not the COPD group, ADC decreased significantly in the anterior-posterior direction by ∼22% (P = 0.006, AMC; 0.0059, HV), likely because of gravity-induced tissue compression. The COPD group exhibited a significantly larger superior-inferior ADC reduction (∼28%) than the healthy groups (∼24%) (P = 0.00018, HV; P = 3.45 × 10-5, AMC), consistent with smoking-related tissue destruction in the superior lung. Superior-inferior gradients in healthy subjects may result from regional differences in xenon concentration. ADC was significantly correlated with pulmonary function tests (forced expiratory volume in 1 sec, r = -0.77, P = 0.0002; forced expiratory volume in 1 sec/forced vital capacity, r = -0.77, P = 0.0002; diffusing capacity of carbon monoxide in the lung/alveolar volume (VA), r = -0.77, P = 0.0002). In healthy groups, ADC increased with age by 0.0002 cm2 sec-1 year-1 (r = 0.56, P = 0.02). This study shows that 129Xe ADC MRI is clinically feasible, sufficiently sensitive to distinguish HV from subjects with emphysema, and detects age- and posture-dependent changes.
KW - apparent diffusion coefficient
KW - chronic obstructive pulmonary disease
KW - pulmonary function testing
UR - http://www.scopus.com/inward/record.url?scp=79952785642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952785642&partnerID=8YFLogxK
U2 - 10.1002/mrm.22697
DO - 10.1002/mrm.22697
M3 - Article
C2 - 21413080
AN - SCOPUS:79952785642
SN - 0740-3194
VL - 65
SP - 1154
EP - 1165
JO - Magnetic Resonance in Medicine
JF - Magnetic Resonance in Medicine
IS - 4
ER -